News Chart Biomind Labs Inc.

Equities

BMND.F

CA0907021012

End-of-day quote OTC Markets Other stock markets 23:00:00 03/04/2024 BST			5-day change	1st Jan Change
0.11 ^USD	-.--%		-.--%	+10.00%

2023	Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications	CI
2023	Biomind Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

b2621b5a7698157ba.MBZtWTLBfZxj-kR3-NOQuDptxBIEOcLG_cNo4SLSWB4.VmcfAQuHNdslkxIBnrCg63EFrFtrTpj3y68Bp2ObFiZDVRhtU4U18iW2cA~7ca3d52da539396429e6416d31cadd6c